盘龙药业：2025年前三季度净利润约8981万元

Group 1 - The core viewpoint of the article highlights the financial performance of Panlong Pharmaceutical in Q3 2025, showing a revenue increase and stable net profit [1] - For the first three quarters of 2025, the company's revenue reached approximately 841 million yuan, representing a year-on-year increase of 17.37% [1] - The net profit attributable to shareholders was about 89.81 million yuan, with a slight year-on-year increase of 0.26% [1] - The basic earnings per share stood at 0.85 yuan, showing no change compared to the previous year [1] Group 2 - As of the report, Panlong Pharmaceutical's market capitalization is 3.3 billion yuan [2]